These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21402401)

  • 1. Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer.
    Ghebre RG; Posthuma R; Vogel RI; Geller MA; Carson LF
    Gynecol Oncol; 2011 Jun; 121(3):595-9. PubMed ID: 21402401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey study.
    Nishio S; Murotani K; Nakao S; Takenaka M; Suzuki S; Aoki Y; Todo Y; Hosaka M; Nakai H; Katabuchi H; Nishi H; Takekuma M; Mikami M; Enomoto T
    Gynecol Oncol; 2020 Nov; 159(2):449-455. PubMed ID: 32854973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and outcomes for elderly women with vulvar cancer over time.
    Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Dizon DS; Schorge JO; del Carmen MG
    BJOG; 2014 May; 121(6):719-27; discussion 727. PubMed ID: 24621118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar carcinoma in Norway: A 50-year perspective on trends in incidence, treatment and survival.
    Meltzer-Gunnes CJ; Småstuen MC; Kristensen GB; Tropé CG; Lie AK; Vistad I
    Gynecol Oncol; 2017 Jun; 145(3):543-548. PubMed ID: 28356187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
    Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
    J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study.
    Hellman K; Holmberg E; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Flöter Rådestad A; Hjerpe E; Högberg T; Marcickiewicz J; Rosenberg P; Stålberg K; Tholander B; Kjølhede P; Åvall-Lundqvist E
    Gynecol Oncol; 2020 Dec; 159(3):663-671. PubMed ID: 32988623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time.
    Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
    Am J Obstet Gynecol; 2013 Nov; 209(5):468.e1-468.e10. PubMed ID: 23891626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulvar cancer: surgical management and survival trends in a low resource setting.
    Kumar N; Ray MD; Sharma DN; Pandey R; Lata K; Mishra A; Wankhede D; Saikia J
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):4. PubMed ID: 32372283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study.
    Nishio S; Matsuo K; Matsuzaki S; Kato T; Kamiura S; Adachi H; Okadome M; Nakamura T; Mikami M; Enomoto T
    Eur J Surg Oncol; 2021 Dec; 47(12):3188-3193. PubMed ID: 34256962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar carcinoma: a retrospective analysis of 80 patients.
    Wagner W; Prott FJ; Weissmann J; Niewöhner-Desbordes U; Ostkamp K; Alfrink M
    Arch Gynecol Obstet; 1999; 262(3-4):99-104. PubMed ID: 10326627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulvar squamous cell carcinoma in women 80 years and older: Treatment, survival and impact of comorbidities.
    Schuurman MS; Veldmate G; Ebisch RMF; de Hullu JA; Lemmens VEPP; van der Aa MA
    Gynecol Oncol; 2023 Dec; 179():91-96. PubMed ID: 37951042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
    Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
    Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Radiation Therapy for Margin-Positive Vulvar Squamous Cell Carcinoma: Defining the Ideal Dose-Response Using the National Cancer Data Base.
    Chapman BV; Gill BS; Viswanathan AN; Balasubramani GK; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):107-117. PubMed ID: 27843030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of squamous cell vulval cancer: a population based retrospective study of 411 cases.
    Rhodes CA; Cummins C; Shafi MI
    Br J Obstet Gynaecol; 1998 Feb; 105(2):200-5. PubMed ID: 9501787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.
    Gaulin NB; Lesnock JL; Tian C; Osei-Bonsu K; Jacobs A; Richard SD; Krivak TC; Miller EM; Shriver CD; Casablanca Y; Maxwell GL; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):136-145. PubMed ID: 31954540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of partnership status on clinical outcomes of patients with vulvar squamous cell carcinoma and performance of sentinel lymph node biopsy.
    Alhatem A; Lambert WC; Karanfilian K; Behbahani S; Heller D
    Int J Gynecol Cancer; 2020 May; 30(5):583-589. PubMed ID: 32184269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant Radiation.
    Dohopolski MJ; Horne ZD; Pradhan D; Bhargava R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):152-160. PubMed ID: 30121234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer.
    Xanthopoulos EP; Grover S; Puri PM; Corradetti MN; Heilbroner SP; Mitra N; Simone CB; Lin LL
    Am J Clin Oncol; 2018 Sep; 41(9):845-850. PubMed ID: 30134287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of performance status on survival in patients of 80 years and older with vulvar cancer.
    Hyde SE; Ansink AC; Burger MP; Schilthuis MS; van der Velden J
    Gynecol Oncol; 2002 Mar; 84(3):388-93. PubMed ID: 11855875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midline involvement as a risk factor for vulvar cancer recurrence.
    Stankevica J; Macuks R; Baidekalna I; Donina S
    Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.